MBX Biosciences, Inc. Common Stock (MBX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for MBX Biosciences, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -13.24x | -9.94x | -23.13x | -28.82x |
| P/B Ratio | 3.12x | 2.39x | -10.40x | -17.68x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||
| Current Ratio | 24.62x | 24.19x | 21.26x | 12.89x |
| Quick Ratio | 24.62x | 24.19x | 21.26x | 12.89x |
| Leverage | ||||
| Debt/Equity | 0.00x | 0.00x | -0.00x | -0.01x |
YoY = year-over-year change. Source: FMP..